Charles J. Arntzen, Ph.D., deputy chancellor and dean of the College of Agriculture and Life Sciences at Texas A&M University, has been reappointed to the National Institutes of Health National Biotechnology Board...of Baton Rouge, La., was elected vice president of the association, and William Mahaffey, vice president of technology development for Ecova Corp

of San Francisco, a privately held company engaged in protein separation technology, immunoassays and drug design, said it named Reinaldo Gomez, Ph.D., as president...Company founder Lawrence Kauvar, Ph.D., will continue as vice president and chief scientist...of Vancouver, British Columbia, a waste treatment concern, said it has named John Reynolds chairman and chief executive of the company and its new Kam Environmental Systems Ltd

Mast Immunosystems of Mountain View, Calif., named Garth Mower as marketing and sales manager for the company's allergy diagnostics in Japan, and appointed Dr. David Mackintosh managing director of its Micon U.K. Ltd...of La Jolla, Calif., said William T. Comer, Ph.D., has been appointed president and chief executive officer

Prior to joining Agouron, Harris held positions in regulatory affairs at Allergan Pharmaceuticals, American McGaw and Nelson Research...of Northvale, N.J., a developer of therapeutics for diabetic and aging complications, hired David L. Neer as vice president of corporate development

He will also be senior vice president of finance and administration and treasurer...Kriebel was previously vice president and controller of Armour Pharmaceutical, a subsidiary of Rhone-Poulenc Rorer...U.S. Bioscience develops drugs to treat cancer and other diseases

of Cambridge, Mass., which is developing neuropharmaceuticals, has named Richard F. Pops as its president and chief executive officer

of Avon, Conn., said it hired Dr. George L. Spitalny as vice president of research and development

Frincke was previously executive director of therapeutic research and development at Hybritech Inc...of Princeton, N.J., has named John G. Cooper chief financial officer, vice president and treasurer...Cooper, who will be DNX's first CFO, has been controller and treasurer since joining the company in 1989. ... (c) 1997 American Health Consultants

TRIPLEX NAMES PRESIDENT Isis Pharmaceuticals of San Diego on Thursday said it has hired Yasunori Kaneko as senior vice president responsible for finance and administration...of The Woodlands, Texas, has appointed James M. Chubb president and chief operating officer

McMullen was president and CEO of Hana Biologics from 1984 through 1989...Carnahan is manager of Internal Cost Analysis and Planning at Johnson & Johnson...Robert E. Boni, Ph.D., former president and chairman of the board of New Jersey steelmaker Armco Inc., has been named to the board of directors of Nova Pharmaceutical Corp

of The Woodlands, Texas, on Friday said it has named Ralph Weaver its president and chief executive officer...Weaver is also senior vice president and chief financial officer of OmniMed Corp., a Houston-based venture investment and management company, which last October purchased a controlling interest in Genosys

Hamilton, who joined the company in 1987, will be responsible for Chiron's investment management, banking relations and risk management, the company said...He will continue as president and chief financial officer of Protos Corp., Chiron's drug design subsidiary...Ruvane retired as president, chief executive officer and chairman of Glaxo Inc

She will be responsible for the operations of the company and the management of the biopharmaceutical product development programs...and president of Immunex's Targeted Genetics unit. (c) 1997 American Health Consultants

Bradley, who comes from Merck Sharp & Dohme Research Laboratories, will lead development of disease-specific applications of antisense and other genetically based therapies

of Cambridge, Mass., said Tuesday that Abraham J. Siegel, Kennett F. Burnes and Robert J. Carpenter were elected to the company's board of directors...Siegel is the Howard W. Johnson professor of management at the Sloan School of Management and a professor in the Department of Economics at the Massachusetts Institute of Technology

APPOINTMENTS AND ADVANCEMENTS ABBOTT LABS ELECTS VP The board of directors of Abbott Laboratories of Abbott Park, Ill., elected Ellen Molleston Walvoord corporate vice president of investor relations

of Thousand Oaks, Calif., on Thursday announced that Dr. Harry F. Hixson, president and chief operating officer, has resigned from the company to pursue other interests...Hixson had been a member of Amgen's management team for more than five years, said Gordon Binder, Amgen's chairman and chief executive officer...BioResearch Ireland of Dublin named as chairman Eugene Corcoran, who heads research and development at Kerry Group plc. (c) 1997 American Health Consultants

At Cetus, Kriegler helped identify and develop small molecules used to treat inflammatory diseases...He also participated in the National Institutes of Health's gene therapy program and was credited with designing the first genetically engineered retrovirus to receive approval from the Food and Drug Administration for the experimental treatment of cancer in humans. (c) 1997 American Health Consultants

BIOTECHNICA MOVE SPURS APPOINTMENTS With BioTechnica International's previously announced relocation of its corporate headquarters to Overland Park, Kan., from Cambridge, Mass., comes appointments to two key management positions...Hall previously held management and staff positions with Commerce Bank of Kansas City, First Interstate Bank Ltd., First National Bank of Chicago and the accounting firm of Peat Marwick